Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1439-7609
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab ; volume:23 ; number:4 ; day:11 ; month:7 ; year:2012 ; pages:827-831 ; date:7.2013
Modern rheumatology ; 23, Heft 4 (11.7.2012), 827-831, 7.2013
- Urheber
-
Araki, Manabu
Aranami, Toshimasa
Matsuoka, Takako
Nakamura, Masakazu
Miyake, Sachiko
Yamamura, Takashi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10165-012-0715-9
- URN
-
urn:nbn:de:101:1-2021080920522603311656
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Araki, Manabu
- Aranami, Toshimasa
- Matsuoka, Takako
- Nakamura, Masakazu
- Miyake, Sachiko
- Yamamura, Takashi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Neuromyelitis optica
Two Cases of Pediatric AQP4-Antibody Positive Neuromyelitis Optica Spectrum Disorder Successfully Treated with Tocilizumab
Interferon-beta-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab
Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab
Neuromyelitis optica spectrum disorders without and with autoimmune diseases
The history of neuromyelitis optica
Schwannzell-Remyelinisierung bei Neuromyelitis optica
The history of neuromyelitis optica
Different monoclonal antibodies and immunosuppressants administration in patients with neuromyelitis optica spectrum disorder: a Bayesian network meta-analysis
Neuromyelitis optica spectrum disorders with and without connective tissue disorders
Neuromyelitis Optica Spectrum Disorder Coinciding with Spinocerebellar Ataxia Type 31
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Neuromyelitis optica
Two Cases of Pediatric AQP4-Antibody Positive Neuromyelitis Optica Spectrum Disorder Successfully Treated with Tocilizumab
Interferon-beta-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab
Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab
Neuromyelitis optica spectrum disorders without and with autoimmune diseases
The history of neuromyelitis optica
Schwannzell-Remyelinisierung bei Neuromyelitis optica
The history of neuromyelitis optica
Different monoclonal antibodies and immunosuppressants administration in patients with neuromyelitis optica spectrum disorder: a Bayesian network meta-analysis
Neuromyelitis optica spectrum disorders with and without connective tissue disorders
Neuromyelitis Optica Spectrum Disorder Coinciding with Spinocerebellar Ataxia Type 31
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Neuromyelitis optica
Two Cases of Pediatric AQP4-Antibody Positive Neuromyelitis Optica Spectrum Disorder Successfully Treated with Tocilizumab
Interferon-beta-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab
Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab
Neuromyelitis optica spectrum disorders without and with autoimmune diseases
The history of neuromyelitis optica
Schwannzell-Remyelinisierung bei Neuromyelitis optica
The history of neuromyelitis optica
Different monoclonal antibodies and immunosuppressants administration in patients with neuromyelitis optica spectrum disorder: a Bayesian network meta-analysis
Neuromyelitis optica spectrum disorders with and without connective tissue disorders